Other Science
151 articles
Research: The Next Generation
AACR young researchers come from all over the world, and add their perspectives to pancreatic cancer studies.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
New Liquid Biopsy Shows Promise for Early Detection
Dr. Ajay Goel has a new approach to a liquid biopsy early detection test for pancreatic cancer. So far, the results are very impressive.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.